Federal Appeals Court Restricts Abortion Pill Access, Requiring In-Person Pickup
A federal appeals court has temporarily reinstated a requirement that abortion pills, specifically mifepristone, be picked up in person rather than sent through the mail. This decision by the U.S. Court of Appeals for the 5th Circuit is seen as a victory for anti-abortion advocates. The ruling stems from a lawsuit filed by Louisiana against the FDA, challenging the agency's rule that allowed the distribution of abortion pills via telehealth and mail. The court's decision is in effect while the case continues, and it has prompted Danco Laboratories, a manufacturer of mifepristone, to file an emergency motion for a pause to seek a Supreme Court opinion. The ruling has significant implications for access to abortion, particularly affecting rural communities and those with limited resources. 
